Sale!

CEP57 Gene Mosaic Variegated Aneuploidy Syndrome Type 2 Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The CEP57 Gene Mosaic Variegated Aneuploidy Syndrome Type 2 Genetic Test is a specialized diagnostic tool offered by DNA Labs UAE, designed to detect mutations in the CEP57 gene, which are linked to Mosaic Variegated Aneuploidy Syndrome Type 2 (MVA Syndrome Type 2). This condition is characterized by a high rate of chromosomal aneuploidy, manifesting in a wide range of clinical symptoms including growth retardation, microcephaly, intellectual disability, and an increased risk of cancer. The test aims to provide a definitive genetic diagnosis for individuals presenting symptoms suggestive of MVA Syndrome Type 2, enabling appropriate clinical management and genetic counseling. Priced at 4400 AED, the test involves collecting a DNA sample from the patient, which is then analyzed for specific mutations in the CEP57 gene that are indicative of the syndrome. This precise genetic testing method helps in the early detection and intervention, potentially improving patient outcomes and providing vital information for family planning decisions.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

CEP57 Gene Mosaic Variegated Aneuploidy Syndrome Type 2 Genetic Test

Genetic testing plays a crucial role in diagnosing and understanding genetic disorders. One such disorder is CEP57 Gene Mosaic Variegated Aneuploidy Syndrome Type 2 (MVA2). DNA Labs UAE offers a comprehensive genetic test for this syndrome.

Test Name: CEP57 Gene Mosaic Variegated Aneuploidy Syndrome Type 2 Genetic Test

Components: Blood or Extracted DNA or One drop Blood on FTA Card

Price: 4400.0 AED

Report Delivery: 3 to 4 Weeks

Method: NGS Technology

Test Type: Dysmorphology

Doctor: Pediatrics

Test Department: Genetics

Pre Test Information: Clinical History of Patient who is going for CEP57 Gene Mosaic Variegated Aneuploidy Syndrome Type 2 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with CEP57 Gene Mosaic Variegated Aneuploidy Syndrome Type 2 NGS Genetic DNA Test gene CEP57

Test Details

CEP57 gene mosaic variegated aneuploidy syndrome type 2 (MVA2) is a rare genetic disorder characterized by mosaic variegated aneuploidy, which refers to the presence of cells with an abnormal number of chromosomes. MVA2 is caused by mutations in the CEP57 gene.

NGS (Next-Generation Sequencing) genetic testing is a diagnostic tool used to identify mutations or variations in genes associated with genetic disorders. It is a high-throughput sequencing method that allows for the simultaneous analysis of multiple genes or the entire exome (the protein-coding region of the genome).

NGS testing can provide a comprehensive analysis of the CEP57 gene and other genes related to mosaic variegated aneuploidy syndrome type 2. By analyzing the patient’s DNA, NGS testing can identify specific mutations or variations in the CEP57 gene that may be responsible for the development of MVA2.

This information can help with accurate diagnosis, genetic counseling, and potentially guide treatment options for individuals with this condition.

It is important to note that genetic testing, including NGS, should be performed by a qualified healthcare professional or genetic counselor who can interpret the results and provide appropriate recommendations based on the individual’s specific situation.

Test Name CEP57 Gene Mosaic variegated aneuploidy syndrome type 2 Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Dysmorphology
Doctor Pediatrics
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for CEP57 Gene Mosaic variegated aneuploidy syndrome type 2 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with CEP57 Gene Mosaic variegated aneuploidy syndrome type 2 NGS Genetic DNA Test gene CEP57
Test Details

CEP57 gene mosaic variegated aneuploidy syndrome type 2 (MVA2) is a rare genetic disorder characterized by mosaic variegated aneuploidy, which refers to the presence of cells with an abnormal number of chromosomes. MVA2 is caused by mutations in the CEP57 gene.

NGS (Next-Generation Sequencing) genetic testing is a diagnostic tool used to identify mutations or variations in genes associated with genetic disorders. It is a high-throughput sequencing method that allows for the simultaneous analysis of multiple genes or the entire exome (the protein-coding region of the genome). NGS testing can provide a comprehensive analysis of the CEP57 gene and other genes related to mosaic variegated aneuploidy syndrome type 2.

By analyzing the patient’s DNA, NGS testing can identify specific mutations or variations in the CEP57 gene that may be responsible for the development of MVA2. This information can help with accurate diagnosis, genetic counseling, and potentially guide treatment options for individuals with this condition.

It is important to note that genetic testing, including NGS, should be performed by a qualified healthcare professional or genetic counselor who can interpret the results and provide appropriate recommendations based on the individual’s specific situation.